Elizabeth A. Brem, MD, highlights upcoming changes in the follicular lymphoma treatment paradigm that could move the field beyond chemotherapy.
Elizabeth A. Brem, MD
Advertisement
Elizabeth A. Brem, MD, is an associate clinical professor of medicine at the University of California Irvine.
Articles by Elizabeth A. Brem, MD
Elizabeth Brem, MD, discusses data for odronextamab monotherapy in previously untreated patients with high-risk follicular lymphoma.
Advertisement
Latest Updated Articles
Dr Brem on Odronextamab in Previously Untreated Patients, High-Risk Follicular LymphomaPublished: January 7th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5